V008-0728 Screening compound: N-{2-[4-(6-{[1,1'-biphenyl]-4-yl}pyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-N-(cyclopropylmethyl)-4-methylbenzene-1-sulfonamide

V008-0728 Screening compound: N-{2-[4-(6-{[1,1'-biphenyl]-4-yl}pyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-N-(cyclopropylmethyl)-4-methylbenzene-1-sulfonamide
V008-0728 Screening compound: N-{2-[4-(6-{[1,1'-biphenyl]-4-yl}pyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-N-(cyclopropylmethyl)-4-methylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-0728
N-{2-[4-(6-{[1,1'-biphenyl]-4-yl}pyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-N-(cyclopropylmethyl)-4-methylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-0728

Molecular Formula

C33H35N5O3S (C33 H35 N5 O3 S)

Compound Name

N-{2-[4-(6-{[1,1'-biphenyl]-4-yl}pyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-N-(cyclopropylmethyl)-4-methylbenzene-1-sulfonamide

IUPAC name

N-{2-[4-(6-{[11'-biphenyl]-4-yl}pyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-N-(cyclopropylmethyl)-4-methylbenzene-1-sulfonamide

SMILES

Cc(cc1)ccc1S(N(CC1CC1)CC(N(CC1)CCN1c(cc1)nnc1-c(cc1)ccc1-c1ccccc1)=O)(=O)=O

InChI

InChI=1S/C33H35N5O3S/c1-25-7-15-30(16-8-25)42(40,41)38(23-26-9-10-26)24-33(39)37-21-19-36(20-22-37)32-18-17-31(34-35-32)29-13-11-28(12-14-29)27-5-3-2-4-6-27/h2-8,11-18,26H,9-10,19-24H2,1H3

InChI Key

QAJGRZCQUBUAHK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19840286

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

581.74

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.952

Distribution Coefficient, logD

5.952

Water Solubility, LogSw

-5.81

Polar Surface Area

72.182

Acid Dissociation Constant (pKa)

23.32

Base Dissociation Constant (pKb)

5.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.30

V008-0728 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V008-0728 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-0728?
Check Price and Availability of V008-0728, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-0728 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-0728
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-0728
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-0728 available by request